ADD2 | Adducin 2 (beta) | Cytoskeleton related proteins
| | | | | Group enriched |
ASIC4 | Acid-sensing (proton-gated) ion channel family member 4 | Predicted membrane proteins
| | | | | Group enriched |
ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BRINP2 | Bone morphogenetic protein/retinoic acid inducible neural-specific 2 | Predicted secreted proteins
| | | | | Group enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CDH20 | Cadherin 20, type 2 | Predicted membrane proteins
| | | | | Group enriched |
CPLX2 | Complexin 2 | | | | | | Group enriched |
DRD5 | Dopamine receptor D5 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
FAIM2 | Fas apoptotic inhibitory molecule 2 | Predicted membrane proteins
| | | | | Group enriched |
FAM163B | Family with sequence similarity 163, member B | Predicted membrane proteins
| | | | | Group enriched |
FNDC9 | Fibronectin type III domain containing 9 | Predicted membrane proteins
| | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
GPR98 | G protein-coupled receptor 98 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
GRIK1 | Glutamate receptor, ionotropic, kainate 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
KCNK9 | Potassium channel, subfamily K, member 9 | Disease related genes FDA approved drug targets Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
LUZP2 | Leucine zipper protein 2 | Predicted secreted proteins
| | | | | Group enriched |
MLC1 | Megalencephalic leukoencephalopathy with subcortical cysts 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MYT1 | Myelin transcription factor 1 | Plasma proteins Transcription factors
| | | | | Group enriched |
NRCAM | Neuronal cell adhesion molecule | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
NSG2 | Neuron-specific protein family member 2 | Predicted membrane proteins
| | | | | Group enriched |
NXPH1 | Neurexophilin 1 | Predicted secreted proteins
| | | | | Group enriched |
S100B | S100 calcium binding protein B | Cancer-related genes Candidate cardiovascular disease genes
| | | | | Group enriched |
SCG2 | Secretogranin II | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SEZ6L | Seizure related 6 homolog (mouse)-like | Predicted membrane proteins
| | | | | Group enriched |
SHANK1 | SH3 and multiple ankyrin repeat domains 1 | Plasma proteins
| | | | | Group enriched |
SLC24A2 | Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 | Predicted membrane proteins Transporters
| | | | | Group enriched |
STMN2 | Stathmin-like 2 | | | | | | Group enriched |
SYNGR3 | Synaptogyrin 3 | Predicted membrane proteins
| | | | | Group enriched |
SYT4 | Synaptotagmin IV | | | | | | Group enriched |
TMCC2 | Transmembrane and coiled-coil domain family 2 | Predicted membrane proteins
| | | | | Group enriched |
TMEM179 | Transmembrane protein 179 | Predicted membrane proteins
| | | | | Group enriched |
UCHL1 | Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Group enriched |
UNC5A | Unc-5 homolog A (C. elegans) | Predicted membrane proteins
| | | | | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | | | | | Group enriched |
ADCY8 | Adenylate cyclase 8 (brain) | Enzymes Predicted membrane proteins
| | | | | Group enriched |
AIFM3 | Apoptosis-inducing factor, mitochondrion-associated, 3 | Mitochondrial proteins
| | | | | Group enriched |
AMH | Anti-Mullerian hormone | Disease related genes Predicted secreted proteins
| | | | | Group enriched |
AQP4 | Aquaporin 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | | | | Group enriched |
ATP1A3 | ATPase, Na+/K+ transporting, alpha 3 polypeptide | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP8A2 | ATPase, aminophospholipid transporter, class I, type 8A, member 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
BAI1 | Brain-specific angiogenesis inhibitor 1 | Cancer-related genes G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
BSN | Bassoon presynaptic cytomatrix protein | Plasma proteins
| | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | | | | | Group enriched |
C14orf23 | Chromosome 14 open reading frame 23 | | | | | | Group enriched |
C1orf173 | Chromosome 1 open reading frame 173 | | | | | | Group enriched |
C2CD4C | C2 calcium-dependent domain containing 4C | | | | | | Group enriched |
CACNA1B | Calcium channel, voltage-dependent, N type, alpha 1B subunit | FDA approved drug targets Plasma proteins Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
CACNG4 | Calcium channel, voltage-dependent, gamma subunit 4 | Predicted membrane proteins Transporters
| | | | | Group enriched |